GGrantIndex
← Leaderboards

Sudha K Shenoy

Duke University

$7,623,703
Attributed
$9,727,212
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$9,727,212 · 4

By mechanism

R01$9,727,212 · 4

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingResponseProteinsRegulationSignal TransductionUbiquitinationDeubiquitinationUbiquitin-Specific ProteasePreventUbiquitin-Protein LigaseMolecularPhosphorylationLinkG-Protein-Coupled ReceptorsIn VivoChronicPost-Translational Protein ProcessingReceptorSmooth Muscle MyocytesFamilyPolyubiquitinationAffectHeart FailureAgonist

Grant awards (24)

Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart$550,823
R01 · FY2024 · HL · contact PI
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart$562,065
R01 · FY2023 · HL · contact PI
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart$562,065
R01 · FY2022 · HL · contact PI
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20$534,626
R01 · FY2022 · HL · contact PI
Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart$562,065
R01 · FY2021 · HL · contact PI
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20$534,626
R01 · FY2021 · HL · contact PI
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20$534,626
R01 · FY2020 · HL · contact PI
Regulation of Vascular Inflammatory Signaling by the Deubiquitinase USP20$533,519
R01 · FY2019 · HL · contact PI
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20$527,209
R01 · FY2017 · HL · contact PI
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20$555,034
R01 · FY2016 · HL · contact PI
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20$468,283
R01 · FY2015 · HL · contact PI
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20$44,520
R01 · FY2015 · HL · contact PI
Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20$474,576
R01 · FY2014 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR Down Regulation$342,723
R01 · FY2014 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR Down Regulation$332,931
R01 · FY2013 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR Down Regulation$349,718
R01 · FY2012 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR Down Regulation$353,250
R01 · FY2011 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR Down Regulation$353,250
R01 · FY2010 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR downregulation$258,854
R01 · FY2009 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR downregulation$237,616
R01 · FY2009 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR downregulation$258,854
R01 · FY2008 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR downregulation$258,854
R01 · FY2007 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR downregulation$265,802
R01 · FY2006 · HL · contact PI
E3 Ligases and Deubiquitinases in GPCR downregulation$271,323
R01 · FY2005 · HL